Spots Global Cancer Trial Database for tumor necrosis factor (tnf)
Every month we try and update this database with for tumor necrosis factor (tnf) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia) | NCT01374971 | Rheumatoid Arth... | Certolizumab Pe... Arthroscopic sy... | 18 Years - | Arthritis Treatment Center, Maryland | |
Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia) | NCT01374971 | Rheumatoid Arth... | Certolizumab Pe... Arthroscopic sy... | 18 Years - | Arthritis Treatment Center, Maryland | |
Hyperbaric Oxygen Therapy for Perianal Fistulizing Crohn's Disease Not Responsive or Intolerant to Conventional Care: HYPNOTIC Pilot Study | NCT06109961 | Inflammatory Bo... | Oxygen Gas for ... Standard of car... | 17 Years - | Ottawa Hospital Research Institute | |
Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation | NCT05321498 | Mild Cognitive ... Alzheimer Disea... Dementia Brain Diseases Central Nervous... Nervous System ... Tauopathies Neurodegenerati... Mental Disorder... | XPro1595 Placebo | 55 Years - 80 Years | Inmune Bio, Inc. | |
Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation | NCT05321498 | Mild Cognitive ... Alzheimer Disea... Dementia Brain Diseases Central Nervous... Nervous System ... Tauopathies Neurodegenerati... Mental Disorder... | XPro1595 Placebo | 55 Years - 80 Years | Inmune Bio, Inc. |